SCHEMBL6800576

SCHEMBL6800576

O=C(OCc1ccccc1)C1C2CCC(O2)C1C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FABP7 O15540 4/20 0.55
▸ FABP5 Q01469 4/20 0.55
▸ PPM1B O75688 2/20 0.51
▸ PTPN1 P18031 2/20 0.51
▸ PPP1CC P36873 2/20 0.51
▸ TSHR P16473 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.47
▸ MAPK1 P28482 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2832823 0.95 PPM1B (0.59) FABP7FABP5PPM1BPTPN1PPP1CC
SCHEMBL2032598 0.88 PPM1B (0.56) FABP7FABP5PPM1BPTPN1PPP1CC
SCHEMBL4269208 0.82 SMN1; SMN2 (0.48) FABP7FABP5TSHRALDH1A1L3MBTL1
SCHEMBL4269550 0.82 SMN1; SMN2 (0.48) FABP7FABP5TSHRALDH1A1L3MBTL1
SCHEMBL715194 0.82 SMN1; SMN2 (0.48) FABP7FABP5TSHRALDH1A1L3MBTL1
SCHEMBL3345699 0.82 SMN1; SMN2 (0.48) FABP7FABP5TSHRALDH1A1L3MBTL1
SCHEMBL3345701 0.82 SMN1; SMN2 (0.48) FABP7FABP5TSHRALDH1A1L3MBTL1
SCHEMBL9880163 0.81 TFPI2 (0.49) FABP7FABP5TSHRNPC1RAB9A
SCHEMBL1572071 0.81 TFPI2 (0.49) FABP7FABP5TSHRNPC1RAB9A
SCHEMBL24535022 0.81 ALDH1A1 (0.51) FABP7FABP5TSHRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040053996-A1 Use of oxabicyclo[2.2.1]heptane derivatives as pesticidal agents BAYER CROPSCIENCE AG (DE) 2004-03-18 — — US disclosed
EP-1339720-A2 USE OF OXABICYCLO 2.2.1]HEPTANE DERIVATIVES AS PESTICIDAL AGENTS Bayer CropScience AG (DE) 2003-09-03 — — EP disclosed
WO-2002042310-A2 OXABICYCLO[2.2.1]HEPTANE DERIVATIVES AS PESTICIDAL AGENTS BAYER CROPSCIENCE AG (DE) 2002-05-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053996-A1 Use of oxabicyclo[2.2.1]heptane derivatives as pesticidal agents DDT, OXER1, CYP4X1 FABP7 3535/4885FABP5 4653/4885PPM1B 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback